Dr. Lal PathLabs

The board declared an interim dividend of 5 per equity share, or 50% of the face value of 10 each, for FY27. The record date for determining eligible shareholders has been fixed as July 30, with the dividend to be paid within 30 days of its declaration.

Shares of Dr Lal PathLabs surged 11.6 per cent on June 16 to hit a 52-week high, even as broader healthcare indices declined nearly 1 per cent. The stock touched Rs 1,803 during the session, driven by company-specific developments and strong investor inte

Dr Lal PathLabs stock has been losing for the last two days and has fallen 7.34 percent in the period.

Dr Lal PathLabs Q4 Results: The diagnostic firm's revenue from operations in the fourth quarter of FY24 rose 11 per cent to 545.5 crore, compared to 491 crore reported in the year-ago period.

Dr Lal PathLabs shares were trading at Rs 2,234.65, up nearly 5 percent from the previous close. The revised price target implies an upside of 8 percent from March 22 closing

Dr Lal Pathlabs' consolidated revenue in Q1FY24 increased 7.6% to 541 crore from 502.7 crore, YoY.

The PathLabs' CFO doesn